Xinyu Zhang – InmunoES

Neuroinflammatory mechanisms and pharmacological advances in autism spectrum disorder: from inflammatory pathways to targeted interventions

20 de May de 2026 by Xinyu Zhang

BackgroundAutism spectrum disorder (ASD) is highly diverse in causes and symptoms, and reliable biomarkers and mechanism-based treatment targets are still lacking. Neuroinflammation has been linked to ASD risk, symptom development, and long-term course…

Plasma proteomic profiling of hospitalized patients co-infected with HIV and SARS-CoV-2

11 de June de 2025 by Xinyu Zhang

BackgroundThe interaction between human immunodeficiency virus (HIV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections presents a critical challenge to immunopathogenesis. While HIV infection induces progressive CD4+ T cell de…

Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis

30 de January de 2025 by Xinyu Zhang

BackgroundIn recent years, immune checkpoint inhibitors (ICIs) have shown significant efficacy in treating various malignancies and have become a key therapeutic approach in cancer treatment. However, while ICIs activate the immune system, they can als…